tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Technical Analysis

Compare
2,251 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Catalyst Pharma’s (CPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.80, suggesting Catalyst Pharma is a Sell.
Catalyst Pharma’s (CPRX) 20-Day exponential moving average is 23.33, while Catalyst Pharma’s (CPRX) share price is $24.69, making it a Buy.
Catalyst Pharma’s (CPRX) 50-Day exponential moving average is 22.64, while Catalyst Pharma’s (CPRX) share price is $24.69, making it a Buy.

Catalyst Pharma (CPRX) Pivot Points

Mar 30, 2025, 08:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.76
24.20
24.52
24.96
25.28
25.72
26.04
Fibonacci
24.20
24.49
24.67
24.96
25.25
25.43
25.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CPRX) Moving Averages

Mar 30, 2025, 08:04 AM
Period
Simple
Exponential
MA5
25.23Sell
24.74Sell
MA10
24.00Buy
24.12Buy
MA20
22.73Buy
23.33Buy
MA50
22.64Buy
22.64Buy
MA100
22.22Buy
21.98Buy
MA200
20.43Buy
20.25Buy
Catalyst Pharma’s (CPRX) 10-Day exponential moving average is 24.12, while Catalyst Pharma’s (CPRX) share price is $24.69, making it a Buy.
Catalyst Pharma’s (CPRX) 100-Day exponential moving average is 21.98, while Catalyst Pharma’s (CPRX) share price is $24.69, making it a Buy.
Catalyst Pharma’s (CPRX) stock price is $24.69 and Catalyst Pharma’s (CPRX) 50-day simple moving average is 22.64, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $24.69 and Catalyst Pharma’s (CPRX) 100-day simple moving average is 22.22, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $24.69 and Catalyst Pharma’s (CPRX) 200-day simple moving average is 20.43, creating a Buy signal.

Catalyst Pharma (CPRX) Technical Indicators

Mar 30, 2025, 08:04 AM
Name
Value
Implied Action
RSI (14)
62.78
Neutral
STOCH (9,6)
74.62
Neutral
STOCHRSI (14)
78.67
Neutral
MACD (12,26)
0.80
Sell
ADX (14)
24.74
Neutral
Williams %R
-24.76
Buy
CCI (14)
91.91
Neutral
ATR (14)
0.89
-
Ultimate Oscillator
62.64
Neutral
ROC
19.45
Buy
Catalyst Pharma’s (CPRX) Relative Strength Index (RSI) is 62.78, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Trend Strength Indicator (ADX) is 24.74, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Commodity Channel Index (CCI) is 91.91, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Price Rate of Change (ROC) is 19.45, creating a Buy signal.

FAQ

Is CPRX a Buy, Hold, or Sell?
Based on CPRX’s technical indicators, CPRX is a Buy.
    What is CPRX’s RSI (14)?
    CPRX’s RSI (14) is 62.78, which suggests CPRX is a Neutral.
      What is CPRX’s MACD?
      CPRX’s MACD is 0.80, which suggests CPRX is a Sell.
        What is CPRX’s 5-day moving average?
        CPRX’s 5-day moving average is 25.23, which suggests CPRX is a Sell.
          What is CPRX’s 20-day moving average?
          CPRX 20-day moving average is 22.73, which suggests CPRX is a Buy.
            What is CPRX’s 50-day moving average?
            CPRX’s 50-day moving average is 22.64, which suggests CPRX is a Buy.
              What is CPRX’s 200-day moving average?
              CPRX’s 200-day moving average is 20.43, which suggests CPRX is a Buy.
                What is CPRX’s Williams % R (14)?
                CPRX’s Williams % R (14) is -24.76, which suggests CPRX is a Buy.
                  What is CPRX’s CCI (14)?
                  CPRX’s CCI (14) is 91.91, which suggests CPRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis